
October 2006 |
|
It seems like every year a new study is released that reverses a previous
health risk/benefit report. Such is the nature of applying scientific methods to
evaluate these questions. As new research is conducted, we expand our knowledge
base and refine our understanding of complex problems. Ultimately, we hope to
arrive at the correct conclusion.
A similar scientific re-examination is currently underway with the pervasive
compound trichloroethylene (TCE). On 27 July 2006, the National Research Council
(NRC), an arm of the National Academy of Sciences (NAS), issued a report
recommending that EPA press forward with a reassessment of the cancer potency of
TCE. It is widely anticipated that this will result in substantially lower
acceptable cleanup criteria. Such a change will drive up remediation costs and
force reopening closed sites to address residual contamination.
TCE is a chlorinated solvent that was used extensively by industry in degreasing
applications. It is relatively resistant to degradation and readily migrates
through soil to contaminate groundwater. TCE contamination is found at more than
half of all EPA Superfund sites and many state program sites around the country.
The question is - how toxic TCE is to humans? Specifically, how much TCE
constitutes an unacceptable risk for developing cancer. Animal studies show that
exposure to TCE is associated with an increased incidence of cancer. Supporting
studies in workers exposed to TCE show a relationship between exposure and
cancer. In 1985, EPA used the studies available at that time to develop a cancer
potency estimate. In the face of new studies suggesting TCE posed a greater
threat, EPA withdrew the cancer estimate and set out to complete a reassessment.
EPA completed the reassessment in 2001 and concluded that TCE was approximately
30 times more potent than previously thought.
Considerable debate surrounded the release of this reassessment with advocates
from the Department of Defense and the Department of Energy (agencies with a
large numbers of TCE contaminated sites) heavily criticizing the scientific
basis for the reassessment. EPA sent the matter to the NAS for it to resolve the
issue of whether the science was acceptable.
The NRC panel concluded that the scientific studies examined by EPA are
scientifically sound and suitable for use. They recommended further study to
determine the mechanism by which TCE causes cancer and to identify populations
most sensitive to these effects. Perhaps most importantly, they urged EPA to
complete the potency reassessment using "currently available data." The
implication here is that the data presently available to EPA, and previously
interpreted by EPA, will lead to a similar reassessment conclusion. TCE cleanup
criteria will go down.
The key numerical criteria that is likely to change as a result of this
assessment is the federal drinking water standard or Maximum Contaminant Level (MCL).
The time and cost required to complete TCE remediation will increase
dramatically if a lower MCL is promulgated. Current remediation techniques
employed to address TCE contaminated groundwater often become less effective at
lower levels of contamination. More innovative approaches using active
bioremediation or nano-scale zero valent iron may be required to achieve site
closure. These techniques actively break down TCE in the subsurface and are
capable of dealing with low level TCE contamination over a wide area.
EPA currently projects to issue a draft TCE potency estimate for public comment
in December 2008 with a finalized value in August 2009, a measured pace
reminiscent of the arsenic reassessment of several years ago. However, several
regulatory jurisdictions currently use or endorse the higher withdrawn EPA
cancer potency estimate. Florida has elected to use the lower (less stringent)
original cancer potency estimate and has adopted a wait-and-see approach. While
we are waiting for EPA to make its final decision on the potency estimate for
TCE, strategic planning should begin now. These plans should consider the
implications that the new TCE cleanup criteria will have on remedial decisions,
property acquisition, and an assessment of legal liability associated with TCE
contaminated property.
Dr. Keith Tolson is a toxicologist working for GeoSyntec Consultants in Tampa
Florida. His practice focuses on human health risk assessment, applied
toxicology and regulatory affairs. He can be reached at (813) 558-0990 or by
email at ktolson@geosyntec.com.